Contract development and manufacturing organisation (CDMO) Saneca Pharma has been granted a multiple dosage form approval for the manufacture and supply of solids, semi-solids and liquid finish dose products to Russia. The company achieved this cGMP certification following an inspection by the Federal State Institution ‘State Institute of Drugs and Good Practices’ of Russia.
With over 70 years of opiate fully backward integrated production we can guarantee the highest quality and full control over the final product delivered to our customers.More Info
Contract development and manufacturing organization (CDMO) Saneca Pharma is driving forward with new research and development initiatives for the manufacture of active pharmaceutical ingredients (APIs) following a €1.5 million grant from the Slovak Ministry of Education, Science, Research and Sport.
The European pharmaceutical industry has grown exponentially over the last ten years. As a result, pharmaceutical manufacturers have faced a number of challenges as droughts, escalating costs, downward price pressure from governments and the need for faster turnaround times to bring new drugs to the market.